<p>根据 Saratoga Research &amp; Investment Management 最近向证券交易委员会提交的 13F 文件，该机构在第二季度获得了 Zoetis Inc.（纽约证券交易所代码：ZTS - 免费报告）的新头寸。这家机构投资者购买了 98,597 股该公司的股票，价值约为 15,376,000 美元。</p>
<ul>
<li>2024 年哪只宠物股票值得关注？</li>
</ul>
<p>其他几家机构投资者和对冲基金最近也调整了对该股票的持有。北达拉斯银行信托公司在第二季度购买了价值约 922,000 美元的 Zoetis 新头寸。Forefront Wealth Partners LLC 在第二季度将其在 Zoetis 的持仓增加了 25.6%。Forefront Wealth Partners LLC 现在拥有 1,580 股该公司的股票，价值 255,000 美元，此前在上个季度又购买了 322 股。B. Riley Wealth Advisors Inc.在第二季度购买了价值约 1,183,000 美元的 Zoetis 新头寸。Newbridge Financial Services Group Inc.在第二季度将其在 Zoetis 的持仓提高了 844.9%。Newbridge Financial Services Group Inc.现在拥有 926 股该公司的股票，价值 144,000 美元，此前在上个季度又购买了 828 股。最后，Advisory Services Network LLC 在第二季度将其在 Zoetis 的持仓提高了 7.0%。Advisory Services Network LLC 现在拥有 26,080 股该公司的股票，价值 3,802,000 美元，此前在上个季度又购买了 1,711 股。92.80% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>华尔街分析师观点</h2>
<p>几位股票研究分析师最近对该公司发表了看法。摩根士丹利在 11 月 10 日的研究报告中将 Zoetis 的目标价从 211.00 美元下调至 175.00 美元，并对该股票给予 “增持” 评级。瑞银集团在 11 月 5 日的研究报告中将 Zoetis 的目标价从 158.00 美元下调至 141.00 美元，并对该公司给予 “中性” 评级。摩根大通在 11 月 5 日的报告中将 Zoetis 的目标价从 230.00 美元下调至 200.00 美元，并对该股票给予 “增持” 评级。巴克莱在 12 月 8 日的研究报告中开始覆盖 Zoetis 的股票。他们对该公司给予 “等权重” 评级，并设定了 136.00 美元的目标价。最后，Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 Zoetis 的 “持有（c-）” 评级。五位分析师对该股票给予了买入评级，七位分析师给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “持有”，共识目标价为 164.20 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
<p><strong>查看我们关于 ZTS 的最新报告</strong></p>
<h2>Zoetis 价格表现</h2>
<p>Zoetis（纽约证券交易所代码：ZTS）周五开盘价为 118.60 美元。该公司的 50 日移动平均价格为 130.95 美元，200 日移动平均价格为 146.08 美元。该公司的债务与股本比率为 1.31，流动比率为 3.64，速动比率为 2.28。该公司的市值为 522.6 亿美元，市盈率为 19.97，市盈增长比率为 2.46，贝塔值为 0.97。Zoetis Inc.的 1 年最低价为 115.25 美元，1 年最高价为 181.85 美元。</p>
<ul>
<li>不断上升的股息使 Zoetis 成为赢家</li>
</ul>
<p>Zoetis（纽约证券交易所代码：ZTS - 获取免费报告）最后一次公布季度财报是在 11 月 4 日，报告显示该季度每股收益（EPS）为 1.70 美元，超出分析师共识预期的 1.62 美元，超出幅度为 0.08 美元。Zoetis 的净利润率为 28.21%，股本回报率为 57.19%。该季度的收入为 24 亿美元，而分析师预期为 24.2 亿美元。在去年同期，该公司每股收益为 1.58 美元。与去年同期相比，Zoetis 的收入增长了 0.5%。Zoetis 已将其 2025 财年的指导目标设定为 6.300-6.400 EPS。整体来看，股票分析师预计 Zoetis Inc.在当前财年将发布 6.07 EPS。</p>
<h2>Zoetis 增加股息</h2>
<p>该公司最近宣布了季度股息，将于 3 月 3 日支付。1 月 20 日的股东将获得每股 0.53 美元的股息。除息日期为 1 月 20 日。这是 Zoetis 之前季度股息 0.50 美元的积极变化。这相当于每年 2.12 美元的股息，股息收益率为 1.8%。Zoetis 的股息支付比率目前为 33.67%。</p>
<h2>Zoetis 公司简介</h2>
<p>（免费报告）</p>
<p>Zoetis Inc.从事动物健康药物、疫苗和诊断产品及服务的发现、开发、生产和商业化，业务遍及美国及国际市场。该公司主要在不同物种之间商业化产品，包括家畜，如牛、猪、家禽、鱼和羊等；以及伴侣动物，包括狗、猫和马。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Zoetis</li>
<li>零售股票投资解析</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>公用事业股票解析 – 如何以及为何投资公用事业</li>
<li>Adobe 在财报后获得提振：长期前景看好</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
<p>在考虑 Zoetis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而硕腾并不在名单上。</p>
<p>虽然硕腾目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

硕腾

<p>Saratoga Research & Investment Management 在第二季度收购了 98,597 股 Zoetis Inc.，价值 15,376,000 美元。其他投资者也调整了他们的持股。分析师对 Zoetis 的评级褒贬不一，普遍维持 “持有” 评级，目标价为 164.20 美元。Zoetis 报告第三季度每股收益为 1.70 美元，超出预期。该公司将季度股息提高至每股 0.53 美元，年收益率为 1.8%</p>

<p>Saratoga Research &amp; Investment Management acquired a new position in Zoetis Inc. (NYSE:ZTS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 98,597 shares of the company's stock, valued at approximately $15,376,000.</p>
<div class="lb-trans"><p>根据 Saratoga Research &amp; Investment Management 最近向证券交易委员会提交的 13F 文件，该机构在第二季度获得了 Zoetis Inc.（纽约证券交易所代码：ZTS - 免费报告）的新头寸。这家机构投资者购买了 98,597 股该公司的股票，价值约为 15,376,000 美元。</p>
</div><ul>
<li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年哪只宠物股票值得关注？</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also recently modified their holdings of the stock. North Dallas Bank &amp; Trust Co. bought a new position in Zoetis in the second quarter worth about $922,000. Forefront Wealth Partners LLC boosted its position in Zoetis by 25.6% during the 2nd quarter. Forefront Wealth Partners LLC now owns 1,580 shares of the company's stock valued at $255,000 after acquiring an additional 322 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in shares of Zoetis during the 2nd quarter worth approximately $1,183,000. Newbridge Financial Services Group Inc. raised its position in shares of Zoetis by 844.9% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 926 shares of the company's stock worth $144,000 after acquiring an additional 828 shares in the last quarter. Finally, Advisory Services Network LLC raised its position in shares of Zoetis by 7.0% in the 2nd quarter. Advisory Services Network LLC now owns 26,080 shares of the company's stock worth $3,802,000 after acquiring an additional 1,711 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金最近也调整了对该股票的持有。北达拉斯银行信托公司在第二季度购买了价值约 922,000 美元的 Zoetis 新头寸。Forefront Wealth Partners LLC 在第二季度将其在 Zoetis 的持仓增加了 25.6%。Forefront Wealth Partners LLC 现在拥有 1,580 股该公司的股票，价值 255,000 美元，此前在上个季度又购买了 322 股。B. Riley Wealth Advisors Inc.在第二季度购买了价值约 1,183,000 美元的 Zoetis 新头寸。Newbridge Financial Services Group Inc.在第二季度将其在 Zoetis 的持仓提高了 844.9%。Newbridge Financial Services Group Inc.现在拥有 926 股该公司的股票，价值 144,000 美元，此前在上个季度又购买了 828 股。最后，Advisory Services Network LLC 在第二季度将其在 Zoetis 的持仓提高了 7.0%。Advisory Services Network LLC 现在拥有 26,080 股该公司的股票，价值 3,802,000 美元，此前在上个季度又购买了 1,711 股。92.80% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several equities research analysts recently weighed in on the company. Morgan Stanley dropped their price target on Zoetis from $211.00 to $175.00 and set an &#34;overweight&#34; rating on the stock in a research report on Monday, November 10th. UBS Group lowered their price objective on Zoetis from $158.00 to $141.00 and set a &#34;neutral&#34; rating for the company in a research report on Wednesday, November 5th. JPMorgan Chase &amp; Co. dropped their target price on shares of Zoetis from $230.00 to $200.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, November 5th. Barclays started coverage on shares of Zoetis in a research note on Monday, December 8th. They issued an &#34;equal weight&#34; rating and a $136.00 price target for the company. Finally, Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Zoetis in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $164.20.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该公司发表了看法。摩根士丹利在 11 月 10 日的研究报告中将 Zoetis 的目标价从 211.00 美元下调至 175.00 美元，并对该股票给予 “增持” 评级。瑞银集团在 11 月 5 日的研究报告中将 Zoetis 的目标价从 158.00 美元下调至 141.00 美元，并对该公司给予 “中性” 评级。摩根大通在 11 月 5 日的报告中将 Zoetis 的目标价从 230.00 美元下调至 200.00 美元，并对该股票给予 “增持” 评级。巴克莱在 12 月 8 日的研究报告中开始覆盖 Zoetis 的股票。他们对该公司给予 “等权重” 评级，并设定了 136.00 美元的目标价。最后，Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 Zoetis 的 “持有（c-）” 评级。五位分析师对该股票给予了买入评级，七位分析师给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “持有”，共识目标价为 164.20 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/31 - 08/04</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
</div><p><strong>Check Out Our Latest Report on ZTS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ZTS 的最新报告</strong></p>
</div><h2>Zoetis Price Performance</h2>
<div class="lb-trans"><h2>Zoetis 价格表现</h2>
</div><p>Shares of NYSE:ZTS opened at $118.60 on Friday. The business has a fifty day moving average price of $130.95 and a 200-day moving average price of $146.08. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The company has a market capitalization of $52.26 billion, a PE ratio of 19.97, a PEG ratio of 2.46 and a beta of 0.97. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $181.85.</p>
<div class="lb-trans"><p>Zoetis（纽约证券交易所代码：ZTS）周五开盘价为 118.60 美元。该公司的 50 日移动平均价格为 130.95 美元，200 日移动平均价格为 146.08 美元。该公司的债务与股本比率为 1.31，流动比率为 3.64，速动比率为 2.28。该公司的市值为 522.6 亿美元，市盈率为 19.97，市盈增长比率为 2.46，贝塔值为 0.97。Zoetis Inc.的 1 年最低价为 115.25 美元，1 年最高价为 181.85 美元。</p>
</div><ul>
<li>Rising Dividend Make Zoetis a Doggone Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>不断上升的股息使 Zoetis 成为赢家</li>
</ul>
</div><p>Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion for the quarter, compared to analysts' expectations of $2.42 billion. During the same quarter in the previous year, the business posted $1.58 EPS. Zoetis's revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Zoetis（纽约证券交易所代码：ZTS - 获取免费报告）最后一次公布季度财报是在 11 月 4 日，报告显示该季度每股收益（EPS）为 1.70 美元，超出分析师共识预期的 1.62 美元，超出幅度为 0.08 美元。Zoetis 的净利润率为 28.21%，股本回报率为 57.19%。该季度的收入为 24 亿美元，而分析师预期为 24.2 亿美元。在去年同期，该公司每股收益为 1.58 美元。与去年同期相比，Zoetis 的收入增长了 0.5%。Zoetis 已将其 2025 财年的指导目标设定为 6.300-6.400 EPS。整体来看，股票分析师预计 Zoetis Inc.在当前财年将发布 6.07 EPS。</p>
</div><h2>Zoetis Increases Dividend</h2>
<div class="lb-trans"><h2>Zoetis 增加股息</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis's previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.8%. Zoetis's dividend payout ratio is currently 33.67%.</p>
<div class="lb-trans"><p>该公司最近宣布了季度股息，将于 3 月 3 日支付。1 月 20 日的股东将获得每股 0.53 美元的股息。除息日期为 1 月 20 日。这是 Zoetis 之前季度股息 0.50 美元的积极变化。这相当于每年 2.12 美元的股息，股息收益率为 1.8%。Zoetis 的股息支付比率目前为 33.67%。</p>
</div><h2>Zoetis Company Profile</h2>
<div class="lb-trans"><h2>Zoetis 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.</p>
<div class="lb-trans"><p>Zoetis Inc.从事动物健康药物、疫苗和诊断产品及服务的发现、开发、生产和商业化，业务遍及美国及国际市场。该公司主要在不同物种之间商业化产品，包括家畜，如牛、猪、家禽、鱼和羊等；以及伴侣动物，包括狗、猫和马。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Zoetis</li>
<li>Retail Stocks Investing, Explained</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>Why Amazon Could Be a $300 Stock Within Weeks</li>
<li>Utilities Stocks Explained – How and Why to Invest in Utilities</li>
<li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Zoetis</li>
<li>零售股票投资解析</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>公用事业股票解析 – 如何以及为何投资公用事业</li>
<li>Adobe 在财报后获得提振：长期前景看好</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ZTS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Zoetis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
</div><p>Before you consider Zoetis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Zoetis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而硕腾并不在名单上。</p>
</div><p>While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然硕腾目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

萨拉托加研究与投资管理公司购买了硕腾公司的新股份 $ZTS